annual CFI:
-$2.68B-$605.33M(-29.20%)Summary
- As of today (May 21, 2025), RPRX annual cash flow from investing activities is -$2.68 billion, with the most recent change of -$605.33 million (-29.20%) on December 31, 2024.
- During the last 3 years, RPRX annual CFI has fallen by -$807.84 million (-43.19%).
- RPRX annual CFI is now -982.63% below its all-time high of $303.42 million, reached on December 31, 2018.
Performance
RPRX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$503.92M+$1.01B(+199.67%)Summary
- As of today (May 21, 2025), RPRX quarterly cash flow from investing activities is $503.92 million, with the most recent change of +$1.01 billion (+199.67%) on March 31, 2025.
- Over the past year, RPRX quarterly CFI has increased by +$590.57 million (+681.55%).
- RPRX quarterly CFI is now at all-time high.
Performance
RPRX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$2.09B+$590.57M(+22.05%)Summary
- As of today (May 21, 2025), RPRX TTM cash flow from investing activities is -$2.09 billion, with the most recent change of +$590.57 million (+22.05%) on March 31, 2025.
- Over the past year, RPRX TTM CFI has dropped by -$486.63 million (-30.40%).
- RPRX TTM CFI is now -217.32% below its all-time high of -$657.88 million, reached on September 30, 2023.
Performance
RPRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RPRX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.2% | +681.5% | -30.4% |
| 3 y3 years | -43.2% | +4413.4% | -65.7% |
| 5 y5 years | -24.4% | +166.2% | -30.6% |
RPRX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -160.2% | at low | at high | +135.4% | -217.3% | +34.2% |
| 5 y | 5-year | -160.2% | +2.9% | at high | +135.4% | -217.3% | +34.2% |
| alltime | all time | -982.6% | +2.9% | at high | +135.4% | -217.3% | +34.2% |
RPRX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $503.92M(-199.7%) | -$2.09B(-22.1%) |
| Dec 2024 | -$2.68B(+29.2%) | -$505.59M(-57.6%) | -$2.68B(-15.6%) |
| Sep 2024 | - | -$1.19B(+33.5%) | -$3.17B(+30.5%) |
| Jun 2024 | - | -$893.18M(+930.8%) | -$2.43B(+51.8%) |
| Mar 2024 | - | -$86.65M(-91.3%) | -$1.60B(-22.8%) |
| Dec 2023 | -$2.07B(+101.4%) | -$1.00B(+121.9%) | -$2.07B(+215.1%) |
| Sep 2023 | - | -$450.66M(+610.4%) | -$657.88M(-59.7%) |
| Jun 2023 | - | -$63.43M(-88.6%) | -$1.63B(+2.1%) |
| Mar 2023 | - | -$558.53M(-234.7%) | -$1.60B(+55.3%) |
| Dec 2022 | -$1.03B(-45.0%) | $414.74M(-129.1%) | -$1.03B(-48.4%) |
| Sep 2022 | - | -$1.43B(+4622.5%) | -$2.00B(+40.9%) |
| Jun 2022 | - | -$30.18M(-370.3%) | -$1.42B(+12.4%) |
| Mar 2022 | - | $11.16M(-102.0%) | -$1.26B(-32.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$1.87B(-32.2%) | -$551.65M(-34.8%) | -$1.87B(-13.1%) |
| Sep 2021 | - | -$845.50M(-770.1%) | -$2.15B(-3.4%) |
| Jun 2021 | - | $126.17M(-121.1%) | -$2.23B(-14.3%) |
| Mar 2021 | - | -$599.30M(-28.0%) | -$2.60B(-5.9%) |
| Dec 2020 | -$2.76B(+28.1%) | -$832.40M(-9.5%) | -$2.76B(+38.7%) |
| Sep 2020 | - | -$920.20M(+275.6%) | -$1.99B(+18.1%) |
| Jun 2020 | - | -$244.97M(-67.8%) | -$1.68B(+5.4%) |
| Mar 2020 | - | -$761.75M(+1112.7%) | -$1.60B(-25.8%) |
| Dec 2019 | -$2.15B(-809.8%) | -$62.82M(-89.8%) | -$2.15B(+3.0%) |
| Sep 2019 | - | -$615.27M(+288.5%) | -$2.09B(+41.7%) |
| Jun 2019 | - | -$158.37M(-88.0%) | -$1.48B(+12.0%) |
| Mar 2019 | - | -$1.32B | -$1.32B |
| Dec 2018 | $303.42M(-119.1%) | - | - |
| Dec 2017 | -$1.59B | - | - |
FAQ
- What is Royalty Pharma annual cash flow from investing activities?
- What is the all time high annual CFI for Royalty Pharma?
- What is Royalty Pharma annual CFI year-on-year change?
- What is Royalty Pharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Royalty Pharma?
- What is Royalty Pharma quarterly CFI year-on-year change?
- What is Royalty Pharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Royalty Pharma?
- What is Royalty Pharma TTM CFI year-on-year change?
What is Royalty Pharma annual cash flow from investing activities?
The current annual CFI of RPRX is -$2.68B
What is the all time high annual CFI for Royalty Pharma?
Royalty Pharma all-time high annual cash flow from investing activities is $303.42M
What is Royalty Pharma annual CFI year-on-year change?
Over the past year, RPRX annual cash flow from investing activities has changed by -$605.33M (-29.20%)
What is Royalty Pharma quarterly cash flow from investing activities?
The current quarterly CFI of RPRX is $503.92M
What is the all time high quarterly CFI for Royalty Pharma?
Royalty Pharma all-time high quarterly cash flow from investing activities is $503.92M
What is Royalty Pharma quarterly CFI year-on-year change?
Over the past year, RPRX quarterly cash flow from investing activities has changed by +$590.57M (+681.55%)
What is Royalty Pharma TTM cash flow from investing activities?
The current TTM CFI of RPRX is -$2.09B
What is the all time high TTM CFI for Royalty Pharma?
Royalty Pharma all-time high TTM cash flow from investing activities is -$657.88M
What is Royalty Pharma TTM CFI year-on-year change?
Over the past year, RPRX TTM cash flow from investing activities has changed by -$486.63M (-30.40%)